In 2003, the United States Congressional Research Service asserted that there is a danger that India may develop a bio weapons programme. It claimed that 'India is believed to have an active......
The life sciences industry in Asia clocked a growth of 3.4 per cent to record revenues of $110.89 billion in the calendar year 2009, with nearly half the revenues -- $54.24 billion -- coming from......
Mumbai outpaced Bangalore, with a margin of about Rs 200 crore (Rs 2 billion), to become India's top biotech city in terms of revenue while Bangalore-based bio pharmaceuticals major Biocon clocked......
Hari S Bhartia, co-chairman & managing director of Jubilant Organosys Ltd, has been elected as the president of the Confederation of Indian Industry for the year 2010-11. He succeeds Venu......
Most of the biotech companies are focusing on discovery-led innovation in biopharmaceuticals. The segment has been witnessing innovations in follow-on (new variants) biologics (commercial products......
Lauding the government's initiative of unveiling a National Biotechnology Policy, industry experts said that it was imperative that this policy was implemented in a timebound manner and that the......